FDA Staff Makes No Recommendation on J&J Covid Shot Booster (1)

Oct. 13, 2021, 3:06 PM

U.S. regulators didn’t make a recommendation on whether recipients of the Johnson & Johnson Covid-19 vaccine should receive a booster, ahead of a closely watched meeting where scientific experts will weigh whether study data supports giving the additional dose.

On Friday, the Food and Drug Administration’s advisers will convene to guide the agency on J&J’s request for an emergency-use authorization of a second shot. In a 54-page report released Wednesday in preparation, the agency’s staff didn’t make a formal recommendation for the panel.

FDA personnel don’t always make a recommendation to the advisory committee. The staff also declined to ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.